subject area of
- A randomized comparative study of esomeprazole 40 mg versus pantoprazole 40 mg for healing erosive oesophagitis: the EXPO study Academic Article
- Acid suppression in healthy subjects following lansoprazole or pantoprazole Academic Article
- Clinical trial: factors associated with freedom from relapse of heartburn in patients with healed reflux oesophagitis - results from the maintenance phase of the EXPO study Academic Article
- Clinical trial: factors associated with resolution of heartburn in patients with reflux oesophagitis - results from the EXPO study Academic Article
- Early Relief of Upper Gastrointestinal Dyspeptic Symptoms: A Survey of Empirical Therapy with Pantoprazole in Canadian Clinical Practice Academic Article
- Esomeprazole 20 mg vs. pantoprazole 20 mg for maintenance therapy of healed erosive oesophagitis: results from the EXPO study1 Academic Article
- Evaluation of GERD Symptoms during Therapy Academic Article
- Evaluation of GERD Symptoms during Therapy Academic Article
- Impact of oesophagitis classification in evaluating healing of erosive oesophagitis after therapy with proton pump inhibitors: a pooled analysis Academic Article
- International Validation of ReQuest™ in Patients with Endoscopy-Negative Gastro-Oesophageal Reflux Disease Academic Article
- Intravenous proton pump inhibitor therapy: a rationale for use. Academic Article
- Lack of a pharmacokinetic interaction between lansoprazole or pantoprazole and theophylline Academic Article
- Novel Approaches to Inhibition of Gastric Acid Secretion Academic Article
- Oral esomeprazole vs. intravenous pantoprazole: a comparison of the effect on intragastric pH in healthy subjects Academic Article
- Oral rabeprazole vs. intravenous pantoprazole: a comparison of the effect on intragastric pH in healthy subjects Academic Article
- Pantoprazole Rapidly Improves Health-Related Quality of Life in Patients With Heartburn Academic Article
- Pantoprazole did not reduce risk for a composite of upper gastrointestinal events in stable arterial disease Academic Article
- Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial Academic Article
- Pantoprazole-induced acute interstitial nephritis Academic Article
- Re-evaluating the Inhibition of Stress Erosions (REVISE): a protocol for pilot randomized controlled trial Academic Article
- Reply Academic Article
- Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin Academic Article
- Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease. Academic Article
- Validation of the GSFQ, a Self-Administered Symptom Frequency Questionnaire for Patients with Gastroesophageal Reflux Disease Academic Article
- Withholding Pantoprazole for Stress Ulcer Prophylaxis in Critically Ill Patients Academic Article